Literature DB >> 6140228

Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II.

B Saletu, J Grünberger, L Linzmayer, A Dubini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6140228

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN： 0174-4879


× No keyword cloud information.
  3 in total

Review 1.  Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Authors:  S J de Visser; J van der Post; M S Pieters; A F Cohen; J M van Gerven
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

2.  Metabolic fate of zetidoline, a new neuroleptic agent, in man.

Authors:  A Assandri; A Perazzi; P Ferrari; E Martinelli; A Ripamonti; G Tarzia; G Tuan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

3.  A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers.

Authors:  G R McClelland; S M Cooper; A J Pilgrim
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.